Compositions including recycled resin components and medical devices and components made form such compositions are disclosed. The compositions and medical devices are characterized as biocompatible and sterilization stable. In one or more embodiments, the compositions include a recycled resin component and may include one or more of an anti-oxidant component, slip additive component, anti-static component, impact modifier component, colorant component, acid scavenger component, X-ray fluorescence agent component, radio opaque filler component, surface modifier component, melt stabilizer component, clarifier component, processing aid component and reinforcing agent component. Methods of forming medical articles and components are also disclosed.

Compositions including recycled resin components and medical devices and components made form such compositions are disclosed. The compositions and medical devices are characterized as biocompatible and sterilization stable. In one or more embodiments, the compositions include a recycled resin component and may include one or more of an anti-oxidant component, slip additive component, anti-static component, impact modifier component, colorant component, acid scavenger component, X-ray fluorescence agent component, radio opaque filler component, surface modifier component, melt stabilizer component, clarifier component, processing aid component and reinforcing agent component. Methods of forming medical articles and components are also disclosed.

Compositions including recycled resin components and medical devices and components made form such compositions are disclosed. The compositions and medical devices are characterized as biocompatible and sterilization stable. In one or more embodiments, the compositions include a recycled resin component and may include one or more of an anti-oxidant component, slip additive component, anti-static component, impact modifier component, colorant component, acid scavenger component, X-ray fluorescence agent component, radio opaque filler component, surface modifier component, melt stabilizer component, clarifier component, processing aid component and reinforcing agent component. Methods of forming medical articles and components are also disclosed.

A method of making a multi-lumen catheter may include disposing an outer surface of a mandrel against an outer surface of a first catheter; disposing a first heat shrink material around the first catheter and the mandrel; heating the first catheter and the mandrel to form a U-shaped channel along the outer surface of the first catheter; removing the first heat shrink material and the mandrel from the first catheter; placing a second catheter into the U-shaped channel; disposing a second heat shrink material around the first catheter and the second catheter such that the second catheter is retained within the U-shaped channel; and heating the first catheter and the second catheter to cause reflow between the first catheter and the second catheter to form the multi-lumen catheter.

A method of making a multi-lumen catheter may include disposing an outer surface of a mandrel against an outer surface of a first catheter; disposing a first heat shrink material around the first catheter and the mandrel; heating the first catheter and the mandrel to form a U-shaped channel along the outer surface of the first catheter; removing the first heat shrink material and the mandrel from the first catheter; placing a second catheter into the U-shaped channel; disposing a second heat shrink material around the first catheter and the second catheter such that the second catheter is retained within the U-shaped channel; and heating the first catheter and the second catheter to cause reflow between the first catheter and the second catheter to form the multi-lumen catheter.

Disclosed herein is a delivery composition for administering a hydrophobic active agent. In one embodiment, a delivery composition for local administration of a hydrophobic active agent to a tissue or organ of a patient is disclosed. In one embodiment, the delivery composition includes a cationic delivery agent, a therapeutically effective amount of a hydrophobic active agent and a pharmaceutically acceptable aqueous carrier. In one embodiment, the cationic delivery agent includes polyethyleneimine (PEI). In an embodiment, the invention includes a drug delivery device including a substrate; and coated therapeutic agent particles disposed on the substrate, the coated therapeutic agent particles comprising a particulate hydrophobic therapeutic agent; and a vinyl amine polymer. Methods of making the delivery composition, as well as kits and methods of use are also included herein.

A catheter includes: a catheter shaft; and a hub on a proximal side of the catheter shaft. The catheter shaft includes a shaft inner surface inclined portion at a proximal portion, the diameter of which increases proximally such that the shaft inner surface inclined portion forms an angle with the catheter central axis. The hub includes a first hub inner surface inclined portion continuous from the shaft inner surface inclined portion and inclined at the same inclination angle as the shaft inner surface inclined portion, and a second hub inner surface inclined portion proximal of the first hub inner surface inclined portion. The second hub inner surface inclined portion inclination angle differs from the first hub inner surface inclined portion inclination angle. The hub does not cover an inner peripheral surface of the catheter shaft in an interlock portion in which the catheter shaft and the hub are interlocked together.

An antimicrobial article, a cell culture article, an antithrombotic article, or a biopharmaceutical article that can reduce adhesion of proteins, blood components, cells, or bacteria containing a copolymer that contains a polymerized unit (A) represented by —CH.sub.2—CHOH— and a polymerized unit (B) represented by —CH.sub.2—CX.sub.2—, wherein Xs are the same as or different from each other, and are each an alkyl group having a linear, branched, or cyclic structure, and optionally containing an oxygen atom between carbon atoms, an alkoxy group having a linear, branched, or cyclic structure, and optionally containing a hetero atom between carbon atoms, a siloxy group having a carbon number of 3 or greater, an ester group containing an aromatic ring or an alkyl group and having a linear, branched, or cyclic structure, or H, excluding those in which both Xs are H.

In various embodiments, a device is provided comprising a balloon configured to expand to an expanded state in response to introduction of a fluid at a first pressure, wherein the fluid perfuses through the balloon above a second pressure, the second pressure being the same or greater than the first pressure. In various embodiments, a method comprising fabricating a balloon configured to expand to an expanded state in response to introduction of a fluid at a first pressure, wherein the fluid perfuses through the balloon above a second pressure, the second pressure being at or greater than the first pressure, disposing the balloon on an elongate member having a lumen, placing the lumen in fluid communication with an interior volume of the balloon.

The invention provides compositions featuring chitosan and polyethylene glycol and methods for using such compositions for the local delivery of biologically active agents to an open fracture, complex wound or other site of infection. Advantageously, the chitosan-PEG compositions can be loaded with one or more antimicrobial agents, including hydrophobic agents, and can be tailored to the needs of particular patients at the point of care (e.g., in a surgical suite, clinic, physician's office, or other clinical setting).